MeiraGTx Holdings plc
MGTX Nasdaq· Biological Products, (No Diagnostic Substances)
Last close · Oct 23, 2026
$9.21
KIRA · Stoqly’s AI analyst, in plain words
- MeiraGTx Holdings plc had $81.4M of revenue in fiscal 2025, up 144.6% on the year before. Over five years, revenue changed +39.2% a year on average.
- Its operating margin was −130.2%, up 363.2 pts: of every 100 in sales, about −130 is left after running the business.
- MeiraGTx Holdings plc lost $114M in fiscal 2025.
- Free cash flow was −$50.2M in fiscal 2025, −61.7% of revenue.
Market cap
$864M
P/E
13.0x
Revenue
$81.4M
Net income
−$114M
Free cash flow
−$50.2M
Operating margin
−130.2%
MeiraGTx Holdings plc in 30 seconds · fiscal 2025
Are sales growing?
+144.6%
Yes. Sales grew 144.6% last year.
Does it make a profit?
−140.3%
No. It lost money last year.
Does profit turn into cash?
−61.7%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 7
Weak. It passes 3 of 7 health tests.
How is the share priced?
13.0x
One share costs 13.0 times its yearly profit per share.
What MeiraGTx Holdings plc does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 30, 2026
- Legal name
- MeiraGTx Holdings plc
- CIK
- 0001735438
MeiraGTx Holdings plc · MGTX
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $37.7M | $15.9M | $14.0M | $33.3M | $81.4M |
| Revenue growth | 142.2% | −57.8% | −12.0% | 137.4% | 144.6% |
| Operating margin | −193.0% | −730.9% | −977.8% | −493.4% | −130.2% |
| Net income | −$79.6M | −$130M | −$84.0M | −$148M | −$114M |
| Net margin | −211.0% | −814.2% | −599.5% | −444.1% | −140.3% |
| Diluted EPS | −$1.80 | −$2.87 | −$1.49 | −$2.12 | −$1.42 |
| Cash | |||||
| Cash from operations | −$10.5M | −$73.1M | −$105M | −$104M | −$46.4M |
| Capital expenditure | $46.4M | $45.0M | $20.2M | $5.0M | $3.8M |
| Free cash flow | −$56.9M | −$118M | −$126M | −$109M | −$50.2M |
| FCF margin | −150.9% | −741.6% | −895.6% | −328.9% | −61.7% |
| Share count change | 17.0% | 2.4% | 25.0% | 23.6% | 15.2% |
| Debt and strength | |||||
| Cash and short-term investments | $138M | $116M | $130M | $104M | $65.9M |
| Shareholders' equity | $185M | $118M | $138M | $67.8M | −$5.8M |
| Current ratio | 2.7x | 1.9x | 2.4x | 2.0x | 0.7x |
| Interest coverage | −252.6x | −23.5x | −10.3x | −12.4x | −8.7x |
| Returns and quality | |||||
| Return on equity | −37.5% | −85.5% | −65.7% | −143.5% | −368.2% |
| Return on tangible equity | −43.3% | −111.4% | −61.3% | −220.6% | — |
| Piotroski F-score | 2 | 1 | 2 | 2 | 3 |
| Altman Z'' | −1.2 | −5.2 | −5.7 | −10.7 | −14.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$4.7M
3 insiders
Of sales under plans
100%
$4.7M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
MeiraGTx Holdings plc · MGTX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $9.21 a share, the company is worth $864M: 13.0 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001735438). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.